Position in VRDN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,163,012
+$206,367 QoQ
Shares Held
117,747
+17.7% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 215 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. VRDN ranks #93 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in VRDN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,163,012 | 117,747 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,956,645 | 100,033 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,032,675 | 97,451 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,252,088 | 104,360 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,501,242 | 107,385 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,409,455 | 104,559 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,915,811 | 99,938 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,009,826 | 88,344 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,181,646 | 90,826 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,182,292 | 67,521 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,316,252 | 60,434 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $928,023 | 60,497 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,415,076 | 59,482 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,347,505 | 52,968 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,380,260 | 47,253 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $715,040 | 34,863 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $366,919 | 31,713 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||